Evidence map›Paper›PMID 25565310›Full record

ArticleKidney international2015

CD11b is protective in complement-mediated immune complex glomerulonephritis.

Jessy J Alexander, Lee D Chaves, Anthony Chang, Alexander Jacob, Maria Ritchie, Richard J Quigg

Abstract read
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. CD11b agonists offer a novel approach for treating lupus nephritis.Translational research : the journal of laboratory and clinical medicine · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Dendritic cell biology and its role in tumor immunotherapy.Journal of hematology & oncology · 2020
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jessy J AlexanderDivision of Nephrology, Department of Medicine, Clinical and Translational Research Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Lee D ChavesDivision of Nephrology, Department of Medicine, Clinical and Translational Research Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Anthony ChangDepartment of Pathology, The University of Chicago, Chicago, Illinois, USA.
Alexander JacobDivision of Nephrology, Department of Medicine, Clinical and Translational Research Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Maria RitchieDivision of Nephrology, Department of Medicine, Clinical and Translational Research Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
Richard J QuiggDivision of Nephrology, Department of Medicine, Clinical and Translational Research Center, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
University at Buffalo, State University of New York · USUniversity of Chicago · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Role of the Complement System in Renal DiseaseR01DK041873 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI QUIGG, RICHARD J. · 1994 to 2011
$3.4M
Nephrology Research Training GrantT32DK007510 · NIDDK · UNIVERSITY OF CHICAGO · PI COE, FREDERIC L · 1986 to 2013
$2.1M
Role of the complement system in renal diseaseR56DK041873 · NIDDK · UNIVERSITY OF CHICAGO · PI QUIGG, RICHARD J · 2006 to 2006
$75k
COMPLEMENT ACTIVATION OF THE GLOMERULER EPITHELIAL CELLR29DK041873 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI QUIGG, RICHARD J · 1989 to 1993
–
NCATS NIH HHS UL1 TR000430NIDDK NIH HHS DK007510NIDDK NIH HHS DK041873NIDDK NIH HHS R01 DK041873NIDDK NIH HHS R56 DK041873NIDDK NIH HHS T32 DK007510
6 · The paper itself

Abstract

In chronic serum sickness, glomerular immune complexes form, yet C57BL/6 mice do not develop glomerulonephritis unless complement factor H (CfH) is absent, indicating the relevance of complement regulation. Complement receptor 3 (CD11b) and Fcγ receptors on leukocytes, and CfH on platelets, can bind immune complexes. Here we induced immune complex-mediated glomerulonephritis in CfH(-/-) mice chimeric for wild-type, CfH(-/-), CD11b(-/-), or FcRγ(-/-) bone marrow stem cells. Glomerulonephritis was worse in CD11b(-/-) chimeras compared with all others, whereas disease in FcRγ(-/-) and wild-type chimeras was comparable. Disease tracked strongly with humoral immune responses, but not glomerular immune complex deposits. Interstitial inflammation with M1 macrophages strongly correlated with glomerulonephritis scores. CD11b(-/-) chimeras had significantly more M1 macrophages and CD4(+) T cells. The renal dendritic cell populations originating from bone marrow-derived CD11c(+) cells were similar in all experimental groups. CD11b(+) cells bearing colony-stimulating factor 1 receptor were present in kidneys, including CD11b(-/-) chimeras; these cells correlated negatively with glomerulonephritis scores. Thus, experimental immune complex-mediated glomerulonephritis is associated with accumulation of M1 macrophages and CD4(+) T cells in kidneys and functional renal insufficiency. Hence, CD11b on mononuclear cells is instrumental in generating an anti-inflammatory response in the inflamed kidney.

Indexed as

AnimalsAntigen-Antibody ComplexApoferritinsBone MarrowCD11b AntigenCD18 AntigensComplement Factor HGlomerulonephritisImmunoglobulin GLeukocytesMice, Inbred C57BLReceptor, Anaphylatoxin C5aReceptors, IgGSerum SicknessAntigen-Antibody ComplexApoferritinsCD11b AntigenCD18 AntigensComplement Factor HImmunoglobulin GReceptor, Anaphylatoxin C5aReceptors, IgG

Identifiers

PMID25565310
PMCPMC4424815
OpenAlexW1967363374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.